Clinical trial registry record

Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 4, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05842928
Last registry update
May 4, 2025
Status
Recruiting
Phase
Phase not reported
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment
352
Countries
Germany
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · HEALTH SERVICES RESEARCH · DOUBLE
Evidence population
Human clinical study registration
Participants
352
Population
ALL · 65 Years
Duration
2023-03-25 to 2026-10-01
Intervention
PARTNER intervention; Control intervention
Comparator
Control Arm
Outcomes measured
Reduction in the PSA-PIM Drug Burden Index (DBI) by ≥ 0.15 points — 6 months; Reduction in the PSA-PIM Drug Burden Index (DBI) by ≥ 0.15 points — 12 months; Frequency of deprescribing PSA-PIM stratified by PSA-PIM subgroups — 12 months; Total exposure with PSA-PIM — 12 months; Total exposure to PSA-PIM stratified by PSA-PIM subgroups — 12 months; Frequency of new PSA-PIM prescriptions — 12 months; Frequency of taking other potentially inappropriate medication (PIM) (Validated PIM lists, e.g. PRISCUS list, START/STO…; Number of falls and hospitalisations due to fall events (Falls diary, Hospitalisation diary according to FIMA) — 12 mon…; Cognition (Verbal Fluency Test) — 12 months; Quality of life (EQ5-D-5L) — 12 months; Insomnia (Regensburg Insomnia Scale; RIS) — 12 months; Adverse drug reactions (ADRs) — 12 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Deprescribing · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.
  • Polypharmacy · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

deprescribingpolypharmacy
Read the original source →Export JSON